Acutus Medical, Inc. (AFIB)

NASDAQ: AFIB · IEX Real-Time Price · USD
0.219
-0.004 (-1.75%)
At close: Feb 23, 2024, 4:00 PM
0.211
-0.007 (-3.38%)
After-hours: Feb 23, 2024, 7:40 PM EST
-1.75%
Market Cap 6.41M
Revenue (ttm) 19.66M
Net Income (ttm) -32.79M
Shares Out 29.30M
EPS (ttm) -1.12
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 639,636
Open 0.216
Previous Close 0.223
Day's Range 0.198 - 0.219
52-Week Range 0.160 - 1.590
Beta 0.16
Analysts n/a
Price Target n/a
Earnings Date Mar 14, 2024

About AFIB

Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. The company was incorporated in 2011 and is headquartered in Ca... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Aug 6, 2020
Employees 225
Stock Exchange NASDAQ
Ticker Symbol AFIB
Full Company Profile

Financial Performance

In 2022, Acutus Medical's revenue was $16.36 million, a decrease of -5.21% compared to the previous year's $17.26 million. Losses were -$39.62 million, -66.34% less than in 2021.

Financial Statements

News

Top 4 Health Care Stocks That Could Blast Off This Quarter - Acutus Medical (NASDAQ:AFIB), Becton Dickinson (NYSE:BDX)

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Other symbols: BDXEGRX
3 months ago - Benzinga

Acutus Medical to Cancel Third Quarter 2023 Conference Call

CARLSBAD, Calif., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), today announced that, following the Company's announcement of its strategic realign...

3 months ago - GlobeNewsWire

Acutus Medical Reports Third Quarter 2023 Financial Results

CARLSBAD, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB) today reported results for the third quarter of 2023.

3 months ago - GlobeNewsWire

Acutus Medical Announces Strategic Realignment of Resources and Corporate Restructuring

CARLSBAD, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), today announced a realignment of resources and corporate restructuring.

3 months ago - GlobeNewsWire

Acutus Medical to Announce Third Quarter 2023 Financial Results

CARLSBAD, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and ...

4 months ago - GlobeNewsWire

Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CARLSBAD, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias a...

4 months ago - GlobeNewsWire

Acutus Medical Reports Second Quarter 2023 Financial Results

CARLSBAD, Calif., Aug. 07, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias a...

7 months ago - GlobeNewsWire

Acutus Medical to Present at the 43rd Annual Canaccord Growth Conference

CARLSBAD, Calif., July 27, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and ...

7 months ago - GlobeNewsWire

Acutus Medical to Announce Second Quarter 2023 Financial Results

CARLSBAD, Calif., July 24, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and ...

7 months ago - GlobeNewsWire

Acutus Medical to Showcase Innovative Cardiac Mapping and Ablation Technologies at HRS 2023

CARLSBAD, Calif., May 15, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and t...

10 months ago - GlobeNewsWire

Acutus Medical Reports First Quarter 2023 Financial Results

CARLSBAD, Calif., May 11, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias ar...

10 months ago - GlobeNewsWire

Acutus Medical to Announce First Quarter 2023 Financial Results

CARLSBAD, Calif., April 28, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and...

10 months ago - GlobeNewsWire

Acutus Medical Announces Preliminary Unaudited First Quarter 2023 Results

CARLSBAD, Calif., April 20, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias ...

11 months ago - GlobeNewsWire

Acutus Medical Reports Fourth Quarter and Full Year 2022 Financial Results

CARLSBAD, Calif., March 16, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias ...

1 year ago - GlobeNewsWire

Acutus Medical to Announce Fourth Quarter and Full Year 2022 Financial Results

CARLSBAD, Calif., March 09, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and...

1 year ago - GlobeNewsWire

Late-Breaking ACQFORCE FLUTTER Trial Meets Primary Endpoint for Safety and Efficacy with the First Gold-Tipped Contact Force Sensing Ablation Catheter

The AcQBlate Force Sensing Ablation Catheter and System demonstrated 94% acute success with no serious adverse events and significantly less ablation time The AcQBlate Force Sensing Ablation Catheter ...

1 year ago - GlobeNewsWire

Acutus Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Results and Appointment of Chief Financial Officer

CARLSBAD, Calif., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias a...

1 year ago - GlobeNewsWire

Acutus Medical Announces Acceptance of the AcQForce Flutter Abstract for Presentation during the Late-Breaking Clinical Trials and First Report Investigations sessions at the 2023 AF Symposium

CARLSBAD, Calif., Dec. 29, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and ...

1 year ago - GlobeNewsWire

Acutus Medical Achieves EU MDR Submission Milestone in Sale of Left-Heart Access Portfolio to Medtronic

CARLSBAD, Calif., Dec. 21, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias a...

1 year ago - GlobeNewsWire

Acutus Medical Announces Full Market Release of next generation software platform AcQMap 8.5

Software improvements further leverage the system's unique ultrasound capabilities for non-contact anatomy reconstruction Software improvements further leverage the system's unique ultrasound capabili...

1 year ago - GlobeNewsWire

Acutus Medical Obtains MDR CE Mark of the AcQMap 3D Imaging and Mapping Catheter

The flagship 3D mapping catheter from Acutus Medical has been certified under the new European Medical Device Regulations The flagship 3D mapping catheter from Acutus Medical has been certified under ...

1 year ago - GlobeNewsWire

Acutus Medical Reports Third Quarter 2022 Financial Results

CARLSBAD, Calif., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias a...

1 year ago - GlobeNewsWire

Acutus Medical to Announce Third Quarter 2022 Financial Results

CARLSBAD, Calif., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and ...

1 year ago - GlobeNewsWire

Acutus Medical Announces Submission of Premarket Approval Application for AcQBlate Force Sensing Ablation Catheter & System

CARLSBAD, Calif., Oct. 18, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias a...

1 year ago - GlobeNewsWire

SHAREHOLDER UPDATE: Glancy Prongay & Murray LLP Appointed Lead Counsel in Securities Class Action Against Acutus Medical, Inc.

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) announces that it has been appointed Lead Counsel in the securities class action against Acutus Medical, Inc. (“Acutus” or the “Compan...

1 year ago - Business Wire